Table 4.
Age group | Correction applieda | Lung | Prostate | Breast | Ovary | Oesophagus | Colorectal | |||
---|---|---|---|---|---|---|---|---|---|---|
Men | Women | Men | Women | Women | Men | Women | Men | Women | ||
55–74 years | No correction | 0.08 | 0.10 | 0.92 | 0.88 | 0.35 | 0.15 | 0.19 | 0.60 | 0.62 |
IHD correction | 0.09 | 0.11 | 0.92 | 0.88 | 0.35 | 0.16 | 0.20 | 0.61 | 0.62 | |
55–64 years | No correction | 0.09 | 0.12 | 0.92 | 0.88 | 0.40 | 0.15 | 0.21 | 0.60 | 0.62 |
IHD correction | 0.10 | 0.12 | 0.92 | 0.88 | 0.40 | 0.16 | 0.21 | 0.60 | 0.62 | |
65–74 years | No correction | 0.07 | 0.09 | 0.93 | 0.87 | 0.30 | 0.14 | 0.17 | 0.60 | 0.61 |
IHD correction | 0.08 | 0.10 | 0.87 | 0.87 | 0.30 | 0.15 | 0.18 | 0.61 | 0.61 |
aDetails of relative risk used in correction can be found in Supplementary Table 3.